Express Pharma

Aleor Dermaceuticals receives US FDA final approval for Lidocaine and Prilocaine cream

The approved ANDA is therapeutically equivalent to the Reference Listed Drug (RLD) product EMLA Cream, 2.5%/2.5%, of Teva Branded Pharma Products R&D

0 185